About
UW
Medicine

Meet UW Medicine
Anticoagulation
Service Pharmacists

About UW Department of
Pharmacy Services

University of Washington
Medical Center
Anticoagulation Services
Modified: Friday, July 20, 2007

ALTERNATIVE MONITORING OPTIONS FOR ANTITHROMBOTIC AGENTS AT THE UNIVERSITY OF WASHINGTON MEDICAL CENTER

Table of Contents

  1. Heparin Activity (Anti factor Xa level)
  2. Direct Thrombin Inhibitor Assay
  3. Chromogenic factor X

===================================================

I. Heparin Activity (Anti factor Xa level) - Used to monitor low molecular weight heparins; or instead of aPTT in patients with antiphospholipid antibodies that might interfere with aPTT, or in patients with presumed heparin resistance as measured by aPTT.

    • For low molecular weight heparins:
      • Peak for twice daily SQ dosing: 0.5 – 1 U/ml (3-4 hours after dose).
      • Peak for once daily SQ dosing: 1 – 1.5 U/ml (3-4 hours after dose)
      • Trough: < 0.5 U/ml

    • For IV unfractionated heparin: 0.3-0.7 U/ml.

Test order code: HEPACT.

Specimen collection: 5ml blue top tube.

II. Direct Thrombin Inhibitor Assay - Used instead of aPTT to assess DTI therapy when patients have antiphospholipid antibodies that might interfere with aPTT results.

    • For argatroban: 60-100 seconds.
    • For bivalirudin: 60-90 seconds.
    • For lepirudin: 90-160 seconds.

Test order code: DTI.

Specimen collection: 3ml or 5ml blue top tube.

III. Chromogenic factor X - Used instead of INR in patients with antiphospholipid antibodies that might interfere with INR, or in patients on concurrent direct thrombin inhibitors that might interfere with INR.

    • For warfarin: 45% - 25% = INR 2 - 4.

Test order code: CHRF10.

Specimen collection: 3ml or 5ml light top tube (citrate).

Report a Site Problem
©2007, University of Washington Anticoagulation Services.
All Rights Reserved.